Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK

PURPOSE: The aim of this study was to evaluate the cost effectiveness of ranibizumab compared with verteporfin photodynamic therapy (vPDT) or no treatment (observation) in patients with visual impairment due to myopic choroidal neovascularization (CNV). METHODS: A Markov model with health states def...

Descripción completa

Detalles Bibliográficos
Autores principales: Claxton, Lindsay, Malcolm, Bill, Taylor, Matthew, Haig, Jennifer, Leteneux, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210643/
https://www.ncbi.nlm.nih.gov/pubmed/25300507
http://dx.doi.org/10.1007/s40266-014-0216-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210643/
https://www.ncbi.nlm.nih.gov/pubmed/25300507
http://dx.doi.org/10.1007/s40266-014-0216-y

Ejemplares similares